<?xml version="1.0" encoding="UTF-8"?>
<p>Many drugs were empirically tried during the epidemic, but no treatment has been shown to consistently improve the outcome of SARS patients, and supportive medical care remains the primary therapy. The case fatality ratio for SARS ranges from 0 % to more than 50 % depending on age group, with an overall estimate of 11 %. Case fatality is estimated to be less than 1 % for people aged 24 years and younger, 6 % for 25–44 years, 15 % for 45–64 years, and over 50 % for people aged 65 years and older (WHO 
 <xref ref-type="bibr" rid="CR27">2003b</xref>).
</p>
